Key points are not available for this paper at this time.
While regulations have advanced product take-back in some markets, challenges to increasing product reuse and remanufacturing remain. Most research to date has focused on original equipment manufacturers taking back and remanufacturing their products, which is often problematic. The present study demonstrates that there are emerging opportunities for small companies with innovative business models to enter the market and advance product end-of-life (EoL) management. The paper examines the biotechnology industry – a growing sector with high spending on lab equipment and relatively short lifespans of research and development instruments. Building on previous research and analysis of industry practices and emerging drivers for product reuse and remanufacturing, the authors propose a framework for sustainable EoL management that includes five managerial drivers: financial benefits, space, ease/convenience, information, and sustainability goals. The paper concludes with discussion of the lessons learned and practical implications for managers in charge of purchasing or disposing of surplus equipment.
Veleva et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: